D.Western Therapeutics Institute, Inc.TSE 4576
株式会社デ・ウエスタン・セラピテクス研究所 · Pharmaceutical · FY ends Dec
Share price at FY-end
—
FY ending Dec 2025
Avg. director pay
¥57.3M
Internal directors
Top 10 shareholders
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|
| 1 |
日高 有一
|
5,150,600 |
9.49% |
— |
— |
| 2 |
楽天証券株式会社共有口
|
2,311,900 |
4.26% |
— |
— |
| 3 |
MSIP Client Securities
|
1,130,200 |
2.08% |
— |
— |
| 4 |
株式会社SBI証券
|
885,918 |
1.63% |
— |
— |
| 5 |
株式会社ミートプランニング
|
850,000 |
1.56% |
— |
— |
| 6 |
日高 万由子
|
730,000 |
1.34% |
— |
— |
| 7 |
SMBC日興証券株式会社
|
592,300 |
1.09% |
— |
— |
| 8 |
日高 弘義
|
428,800 |
0.79% |
— |
— |
| 9 |
日本証券金融株式会社
|
360,500 |
0.66% |
— |
— |
| 10 |
モルガン・スタンレーMUFG証券株式会社
|
306,113 |
0.56% |
— |
— |
Officers' holdings and pay
| Name | Title | Shares | Value | Pay |
|---|
| 日高 有一 |
President & Representative Director |
5,150,600 |
— |
— |
| 松原 さや子 |
Director |
44,600 |
— |
— |
| 山田 富士雄 |
Director |
— |
— |
— |
| 山川 善之 |
Director |
18,000 |
— |
— |
| 中村 栄作 |
Director |
100 |
— |
— |
| 中村 和史 |
Director |
— |
— |
— |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
Per-share data by fiscal year
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|
| FY ending Dec 2025 |
— |
¥-13.19 |
— |
— |
54,251,712 |
| FY ending Dec 2024 |
— |
¥-36.74 |
— |
— |
41,625,512 |
| FY ending Dec 2023 |
— |
¥-25.56 |
— |
— |
32,128,012 |
| FY ending Dec 2022 |
— |
¥-14.50 |
— |
— |
30,871,138 |
| FY ending Dec 2021 |
¥649 |
¥-5.08 |
— |
— |
29,358,600 |
| FY ending Dec 2020 |
¥649 |
¥-10.16 |
— |
— |
29,251,100 |
| FY ending Dec 2019 |
¥649 |
¥5.07 |
128.0x |
— |
26,275,200 |
| FY ending Dec 2018 |
¥649 |
¥-28.51 |
— |
— |
26,275,200 |
| FY ending Dec 2017 |
¥649 |
¥-59.89 |
— |
— |
26,258,400 |
| FY ending Dec 2016 |
— |
¥-10.46 |
— |
— |
24,758,400 |
Source: annual securities reports on EDINET. Values are estimates.
Methodology